Cutting-edge technology optimizes cancer therapy with nanomedicine drug combinations

[News]

UCLA bioengineers develop platform that offers personalized approach to treatmentIn greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer...

More... (http://www.medicalnewstoday.com/releases/289948.php)